Efficacy and safety of dopamine agonists in patients treated with antipsychotics and presenting a macroprolactinoma.

MLA

Ucl - Sss, IREC/EDIN-Pôle d’endocrinologie, diabète et nutrition, et al. “Efficacy and Safety of Dopamine Agonists in Patients Treated with Antipsychotics and Presenting a Macroprolactinoma.” European Journal of Endocrinology, Vol. 183, No.2, p. 221-231 (2020), 2020. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1288278599&authtype=sso&custid=ns315887.

APA

Ucl - Sss, I.-P. d’endocrinologie, diabète et nutrition, UCL - (SLuc) Service d’endocrinologie et de nutrition, Allard, L., Albarel, F., Bertherat, J., Caron, P. J., Cortet, C., Courtillot, C., Delemer, B., Jublanc, C., Maiter, D., Nunes, M. L., Raverot, G., Sarfati, J., Salenave, S., Corruble, E., Choucha, W., & Chanson, P. (2020). Efficacy and safety of dopamine agonists in patients treated with antipsychotics and presenting a macroprolactinoma. European Journal of Endocrinology, Vol. 183, No.2, p. 221-231 (2020).

Chicago

Ucl - Sss, IREC/EDIN - Pôle d’endocrinologie, diabète et nutrition, UCL - (SLuc) Service d’endocrinologie et de nutrition, Lucie Allard, Frédérique Albarel, Jérôme Bertherat, Philippe Jean Caron, Christine Cortet, et al. 2020. “Efficacy and Safety of Dopamine Agonists in Patients Treated with Antipsychotics and Presenting a Macroprolactinoma.” European Journal of Endocrinology, Vol. 183, No.2, p. 221-231 (2020). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1288278599&authtype=sso&custid=ns315887.